Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Cash from Operations (2023 - 2025)

Incannex Healthcare's Cash from Operations history spans 3 years, with the latest figure at 4637000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 17.59% year-over-year to 4637000.0; the TTM value through Dec 2025 reached 18428000.0, down 16.16%, while the annual FY2025 figure was 12500000.0, 21.11% up from the prior year.
  • Cash from Operations for Q4 2025 was 4637000.0 at Incannex Healthcare, up from 9163000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1469000.0 in Q2 2025 and bottomed at 9163000.0 in Q3 2025.
  • The 3-year median for Cash from Operations is 3996500.0 (2024), against an average of 4214500.0.
  • The largest annual shift saw Cash from Operations skyrocketed 60.95% in 2024 before it crashed 308.15% in 2025.
  • A 3-year view of Cash from Operations shows it stood at 2103000.0 in 2023, then plummeted by 167.57% to 5627000.0 in 2024, then increased by 17.59% to 4637000.0 in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Cash from Operations are 4637000.0 (Q4 2025), 9163000.0 (Q3 2025), and 1469000.0 (Q2 2025).